6 Pulmonary Hypertension Clinical Trials in Hartford, CT (2026)

Q: How do I join a clinical trial in Hartford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you.

Recruiting Pulmonary Hypertension Studies in Hartford

NCT07419321Recruiting

Social Isolation and Aging in Schizophrenia

Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk of premature mortality, with a 10-20-year shorter lifespan relative to the general popula...

Hartford, CT650 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04580134Recruiting

CLOZAPINE Response in Biotype-1

The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a st...

Hartford, CT524 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06740383Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bi...

Hartford, CT320 participantsBeth Israel Deaconess Medical Center

View Study Details

NCT05303064Recruiting

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine...

Hartford, CT220 participantsAlkermes, Inc.

View Study Details

NCT06035120Recruiting

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

This is a prospective, open-label, multi-center, single-arm study planned to enroll 200 subjects with heterogeneous emphysema and collateral ventilation (CV) in the target lobe. Subjects will undergo ...

Hartford, CT200 participantsPulmonx Corporation

View Study Details

NCT06129240Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH....

Hartford, CT80 participantsLiquidia Technologies, Inc.

View Study Details

About Pulmonary Hypertension Clinical Trials in Hartford

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 6 pulmonary hypertension clinical trials recruiting participants in Hartford, CT. These studies are seeking a combined 1,994 participants. Research is being sponsored by Icahn School of Medicine at Mount Sinai, University of Texas Southwestern Medical Center, Beth Israel Deaconess Medical Center and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Hartford — FAQ

Are there pulmonary hypertension clinical trials in Hartford?

Yes, there are 6 pulmonary hypertension clinical trials currently recruiting in Hartford, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hartford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.

Are clinical trials in Hartford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 6 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 13, 2026 from ClinicalTrials.gov